Lv13
60 积分 2022-12-08 加入
Strategies to reduce the use of non-human primates in the development of oncology therapeutics: CD3-bispecifics
17小时前
已完结
Comparative Analyses of Poly(ADP-Ribose) Polymerase Inhibitors
4天前
已完结
Comparative Analyses of Poly(ADP-Ribose) Polymerase Inhibitors
4天前
已完结
Dual-payload ADCs move into first oncology clinical trials
4天前
已完结
Response and Resistance to RAS Inhibition in Cancer
4天前
已完结
Toxicologic Pathology Forum: Considerations Regarding Determination of Adversity for Immunopathology Findings in Nonclinical Toxicology Studies with Immune-Modulating Therapeutics
11天前
已完结
Hepatic Bile Acid Transporters and Drug-induced Hepatotoxicity
11天前
已完结
Historical Control Background Incidence of Spontaneous Neoplastic Lesions of Sprague-Dawley Rats in 104-Week Toxicity Studies
11天前
已完结
Strategies to reduce the use of non-human primates in development of oncology ADCs with cytotoxic payloads
11天前
已完结
Assessing the toxicity of bispecific antibodies
15天前
已完结
皖公网安备34019202002308
